PBKM started cooperation with Dystrogen Therapeutics

The Polish Stem Cell Bankestablished cooperation with the biotechnology company Dystrogen Therapeutics. The agreement will enable joint research on chimeric cells and PBKM's production of ATMP stem cells based medicinal products - PBKM informed in apress release. Dystrogen Therapeutics SA was founde...


Acquisition of BioCell Lugano, Switzerland

FamiCord Group acquired BioCell Lugano with amodern laboratory in Switzerland. This is another important step towards expanding the scope of activities in Europe.